Erbitux extends the life of lung cancer patients — a little. Word on what may be the most-discussed study at this year’s American Society of Clinical Oncology conference leaked out early today, with results showing that the drug extended survival for lung cancer patients by just over a month.
Roy Herbst, an M.D. Anderson lung cancer [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment